Greenstone, Eisai to launch authorized generic of Aricept
PEAPACK, N.J. The generics division of Pfizer will sell an authorized generic version of a drug used to treat dementia.
Greenstone said Wednesday that it had agreed with Eisai to launch donepezil hydrochloride tablets, an authorized generic of Aricept. The drug is used to treat dementia related to Alzheimer’s disease. Eisai makes the drug under a partnership with Pfizer.
“We are excited about the opportunity to work with Eisai to introduce this important authorized generic to patients,” said James Cannon, Greenstone’s VP business alliances. “First and foremost, our goal is to provide donepezil hydrochloride tablets to the broad customer base, and we also strive to remain competitive with other potential generic versions of the product.”
Unlike generic drugs, which are marketed in competition with their branded counterparts and must undergo an abbreviated regulatory approval process through the Food and Drug Administration, authorized generics are essentially branded drugs marketed under their generic names with the authorization of the original drug’s manufacturer and often through third-party companies.
Greenstone to launch Authorized Generics Alliance
PEAPACK, N.J. The generics subsidiary of Pfizer is launching a new business focused on authorized generics.
Greenstone announced Tuesday the launch of the Authorized Generics Alliance, which it said would combine its business model and 17 years of experience in the generics market with the expertise of other drug makers to market authorized generics in the United States under the Greenstone label.
“Greenstone is one of the longest-running and most respected marketers of innovator-authorized generics in the United States,” Greenstone general manager Michael Sweitzer said. “As part of Pfizer, Greenstone has the backing of the company’s 161-year expertise in innovation, integrity, quality and supply reliability.”
Unlike generic drugs, which are approved under an abbreviated regulatory approval process by the Food and Drug Administration after the branded drug company’s market exclusivity has expired and compete with their branded counterparts, authorized generics are branded drugs sold under their generic names with permission from the branded drug maker, often through third-party companies.
ProPhase Labs picks agency of record
DOYLESTOWN, Pa. ProPhase Labs on Tuesday announced it has retained media solutions company Women’s Marketing as its agency of record. The agency will work closely with ProPhase Labs to develop and implement high-impact media campaigns for Cold-Eeze and Kids-Eeze across a variety of networks, the company stated.
The ad campaigns coincide with improvements to Cold-Eeze and Kids-Eeze product and packaging, including a Kids-Eeze line of symptom relievers in a "chew" form.
“ProPhase Labs has been working hard to further improve our current product lines and bring new, effective products to market,” stated Ted Karkus, ProPhase CEO. “We are excited to join with WMI to create a dynamic media campaign that will introduce our new and improved products to new consumers and reinvigorate our loyal customers.”